Greenwich LifeSciences (GLSI) Provides Update on Phase III Trial

Go back to Greenwich LifeSciences (GLSI) Provides Update on Phase III Trial
(NASDAQ: GLSI) Delayed: 19.01 +0.44 (2.37%)
Previous Close $18.57    52 Week High
Open $18.93    52 Week Low
Day High $19.35    P/E N/A 
Day Low $18.28    EPS
Volume 93,514